Neuburgh Advisers’s GSK GSK Stock Holding History

Neuburgh Advisers’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,862	Closed	-$294K	–	910
2018 Q3	$294K	Hold	5,862	–	–	0.01%	621
2018 Q2	$295K	Hold	5,862	–	–	0.01%	553
2018 Q1	$286K	Hold	5,862	–	–	0.01%	555
2017 Q4	$260K	Hold	5,862	–	–	0.01%	586
2017 Q3	$297K	Hold	5,862	–	–	0.01%	511
2017 Q2	$316K	Hold	5,862	–	–	0.01%	474
2017 Q1	$309K	Hold	5,862	–	–	0.01%	428
2016 Q4	$282K	Buy	+5,862	New	+$290K	0.01%	416

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Neuburgh Advisers's GSK Position: Q4 2018 in Review

Neuburgh Advisers sold out of GSK (GSK) in Q4 2018, closing a stake of 5,862 shares — an estimated $294K sold.

Neuburgh Advisers first reported a position in GSK in Q4 2016 and held it in 8 quarters. The position peaked at $316K in Q2 2017. 799 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

Neuburgh Advisers reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
Neuburgh Advisers sold 5,862 GSK shares in Q4 2018, an estimated $294K.
Neuburgh Advisers first reported a position in GSK in Q4 2016 and held it in 8 quarters.
Neuburgh Advisers's GSK position peaked at $316K in Q2 2017.
799 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Neuburgh Advisers's 13F filing for Q4 2018, filed 13 Feb 2019.